Therapy Optimization and Challenges in MRD-positive or recurrent Philadelphia Chromosome-positive acute Lymphocytic Leukemia (Ph plus ALL)

首页> 外文期刊>Oncology research and treatment. >Therapy Optimization and Challenges in MRD-positive or recurrent Philadelphia Chromosome-positive acute Lymphocytic Leukemia (Ph plus ALL)

【24h】

Therapy Optimization and Challenges in MRD-positive or recurrent Philadelphia Chromosome-positive acute Lymphocytic Leukemia (Ph plus ALL)

机译：治疗优化和挑战MRD阳性或复发性费城染色体阳性急性淋巴细胞白血病（pH加全部）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2019年第11期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Therapy Optimization and Challenges in MRD-positive or recurrent Philadelphia Chromosome-positive acute Lymphocytic Leukemia (Ph plus ALL) [J] . Oncology research and treatment. . 2019,第11期

机译：治疗优化和挑战MRD阳性或复发性费城染色体阳性急性淋巴细胞白血病（pH加全部）
2. Complicated and Advanced Atherosclerosis in a Young Woman With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Success and Challenges of BCR/ABL1-Targeted Cancer Therapy [J] . Herrmann Joerg, Bell Malcolm R., Warren Rebekkah L., Mayo Clinic Proceedings . 2015,第8期

机译：费城染色体阳性急性淋巴细胞白血病的年轻妇女的复杂和晚期动脉粥样硬化：BCR / ABL1靶向癌症治疗的成功与挑战
3. Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practice. [J] . Yanada M, Naoe T Leukemia and lymphoma . 2006,第9期

机译：伊马替尼联合化疗治疗费城染色体阳性的急性淋巴细胞白血病：当前实践中的主要挑战。
4. Prediction of Drug Application Optimization Based on RBC Dynamics in Maintenance Chemotherapy of Acute Lymphoblastic Leukemia Maintenance [C] . Probir K. Dhar, Tarun K. Naskar, Durjoy Majumder International Conference on Bioinformatics and Systems Biology . 2018

机译：基于RBC动力学的急性淋巴细胞白血病维持化疗的药物应用优化预测。
5. Exposure to oxygen and phototherapy during the perinatal period and their potential effects on acute lymphocytic leukemia. [D] . Artaman, Ali. 2006

机译：围产期接触氧气和光疗及其对急性淋巴细胞白血病的潜在影响。
6. Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells [O] . Mark B. Geyer, Shwetha H. Manjunath, Andrew G. Evans, -1

机译：利用靶向CD19的CAR T细胞同时治疗慢性淋巴细胞白血病和费城染色体阳性的急性淋巴细胞白血病
7. A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy [O] . Borthakur, Gautam, Dombret, Herve, Kantarjian, Hagop, 2015

机译：danusertib（PHA-739358）在患有伊马替尼和/或其他第二代c-ABL治疗耐药或不耐伊马替尼的成年期或成年期慢性髓样白血病和费城染色体阳性急性淋巴细胞白血病的成年患者中进行的一项I期研究
8. Quantitative Risk Assessment of Exposures to Butadiene in European Union Occupational Settings Based on the University of Alabama at Birmingham Epidemiology Study: Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia, and Chronic Myelogenous Leukemia [R] . Silken, R. L., Valdez-Flores, C. 2007

机译：基于阿拉巴马大学伯明翰分校的流行病学研究：急性髓性白血病，慢性淋巴细胞白血病和慢性粒细胞白血病，欧盟职业环境中丁二烯暴露的定量风险评估

Therapy Optimization and Challenges in MRD-positive or recurrent Philadelphia Chromosome-positive acute Lymphocytic Leukemia (Ph plus ALL)

著录项

相似文献

相关主题

期刊订阅